Friday, February 06, 2015

          Can Patents Last Forever? Prof. Feldman on Kimble v. Marvel

          Sample alt tag.
          See story for link to full brief.

          Can patents last forever?

          If the patent holder makes you sign a contract like that, is it enough to completely avoid the 20-year time limit in the patent system? Is it okay if you are just trying to extend your payments, because you don’t have enough money right now? These are the questions embedded in the case of Kimble v. Marvel, says Professor Robin C. Feldman, who, along with Professor Alice Armitage and the Institute for Innovation Law, filed a Supreme Court amicus brief this week in support of neither party.

          The full brief is available online. Click here to access.  

          Highlights

          A summary of the argument beginning on the bottom of page 2-7 of this brief describes what is happening, but highlights are the following:

          • The case concerns contracts in which the patent holder insists on receiving royalty payments after the patent expires. The doctrine of patent misuse, however, frowns on attempts to expand the time or scope of the patent.
          • Over the last few decades, some lower courts have tried to eliminate the doctrine of patent misuse by holding that patent misuse exists only if the behavior rises to the level of an antitrust violation
          • Petitioners in this case ask the Supreme Court to apply the antitrust rule of reason to patent misuse cases. The antitrust rule of reason, which is complex and burdensome, is commonly perceived to be the death knell for any antitrust case and would certainly be the death knell for patent misuse cases
          • In the brief, Professor Feldman argues that patent law is not antitrust law, and antitrust tests are not appropriate for patent law questions.
          • Antitrust law is primarily concerned with parties that have market power, but the patent rules apply to all patent holders, regardless of whether they have market power; One cannot ask the patent office to extend the patent for a few years because 20 years is not long enough to determine its true value.That is a decision for Congress to make
          • Nothing changes if the 20-year term is ill-suited for a particular industry, such as the life sciences. (A number of life science groups have filed amicus briefs as ell.) Any arguments to this effect are appropriately directed to Congress.
          • It is certainly true that when the patent term ends, the patent holder will no longer be able to exclude all others from the use of its invention. With the patent system, however, every potential innovator matters. A contract provision that limits the capacity and incentive for even one potential innovator to make scientific leaps after the expiration of the patent disrupts the balances created by Congress in the Patent Act.
          • Professor Feldman urges the Court to clarify that antitrust principles are not appropriate for a patent law, and to allow the courts to develop flexible approaches, based on patent principles, to this types of licensing issues.

          MEDIA CONTACT:  

          Alex A.G. Shapiro
          Director, Communications & Public Affairs
          UC Hastings College of the Law
          Office: (415) 581-8842
          Cell: (415) 813-9214
          Email: shapiroa@uchastings.edu

          Go to News Archive

          Share this Story

          Share via Facebook
          Share via TwitterShare via EmailPrint Friendly Version

          Other Recent Stories/ RSS

          Tuesday, September 19, 2017

          3L Griffin Estes advocates for the marginalized people of San Francisco

          The Managing Director of the Brennan Award-winning Hastings Homeless Legal Services discusses the critical skills needed to pursue a career in public interest and social justice.
          Monday, September 18, 2017

          Student Group Champions Reproductive Justice

          Members of the UC Hastings chapter of If/When/How are making a difference through lobbying, fundraising and career development.
          Friday, September 15, 2017

          The Slants - Live from UC Hastings

          2L Jeremy Chan, president of APALSA, reflects on how the student organization partnered with SFIPLA to bring the headline-making band to UC Hastings to perform and discuss their U.S. Supreme Court victory.
          Wednesday, September 13, 2017

          Community Connections

          La Raza Law Students Association works for diversity in the classroom and the courtroom.
          Monday, September 11, 2017

          Coping With Concentration- Tim Greaney researches regulatory measures to combat increasing healthcare costs for Health Affairs

          Professor Greaney’s commentary suggests that regulations should target the real culprits, providers with market power and the ability to stifle competition.
          Go to News Archive